CDK8 and neoplasm: Remarkably, many of the stromal genes were affected not only by systemic treatment with a CDK8/19i but also by Mediator kinase mutagenesis in tumor cells alone, suggesting that CDK8/19 activity in the tumor cells molds the tumor microenvironment.